-
Rani Therapeutics' (RANI) Buy Rating Reaffirmed at Canaccord Genuity Group
Источник: Buzz FX / 27 фев 2025 13:01:20 America/New_York
Rani Therapeutics' (RANI) Buy Rating Reaffirmed at Canaccord Genuity Group Written by MarketBeat February 27, 2025 Share Link copied to clipboard. Rani Therapeutics ( NASDAQ:RANI - Get Free Report ) 's stock had its "buy" rating reissued by
Read more...